Dow Inc./ US2605571031 /
5/22/2024 5:42:33 PM | Chg. -1.0200 | Volume | Bid6:04:29 PM | Ask6:04:29 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
53.2900EUR | -1.88% | 54 Turnover: 2,876.6400 |
53.1500Bid Size: 400 | 53.2000Ask Size: 400 | 37.43 bill.EUR | - | - |
GlobeNewswire
2/13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
1/22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
11/16/2023
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
10/11/2023
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
9/6/2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
11/17/2021
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year